Evidence map›Paper›PMID 30721707›Full record

ArticleLife sciences2019

Atorvastatin inhibits pro-inflammatory actions of aldosterone in vascular smooth muscle cells by reducing oxidative stress.

Thiago Bruder-Nascimento, Glaucia E Callera, Augusto C Montezano, Eric J Belin de Chantemele, Rita C Tostes, Rhian M Touyz

Open access · hybridAbstract read
In one paragraph

Article in Life sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Cardiometabolic Disorder and Erectile Dysfunction.Cell biochemistry and biophysics · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Aldosterone, Inflammation, Immune System, and Hypertension.American journal of hypertension · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 4 countries.

Thiago Bruder-NascimentoDepartment of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Brazil; Kidney Research Centre, University of Ottawa, Canada; Vascular Biology Center, Medical College of Georgia, Augusta University, United States of America.
Glaucia E CalleraKidney Research Centre, University of Ottawa, Canada.
Augusto C MontezanoKidney Research Centre, University of Ottawa, Canada; Institute of Cardiovascular and Medical Sciences, University of Glasgow, UK.
Eric J Belin de ChantemeleVascular Biology Center, Medical College of Georgia, Augusta University, United States of America.
Rita C TostesDepartment of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Brazil.
Rhian M TouyzKidney Research Centre, University of Ottawa, Canada; Institute of Cardiovascular and Medical Sciences, University of Glasgow, UK. Electronic address: Rhian.Touyz@glasgow.ac.uk.
University of Ottawa · CAAugusta University · USUniversidade de São Paulo · BRUniversity of Glasgow · GB

Funding

Aldosterone Contribution to Leptin-mediated Hypertension in Obese FemalesR01HL130301 · NHLBI · AUGUSTA UNIVERSITY · PI BELIN DE CHANTEMELE, ERIC J · 2016 to 2020
$1.9M
NHLBI NIH HHS R01 HL130301
6 · The paper itself

Abstract

Vascular inflammatory responses play an important role in several cardiovascular diseases. Of the many pro-inflammatory vasoactive factors implicated in this process, is aldosterone, an important mediator of vascular oxidative stress. Statins, such as atorvastatin, are cholesterol-lowering drugs that have pleiotropic actions, including anti-oxidant properties independently of their cholesterol-lowering effect. This study investigated whether atorvastatin prevents aldosterone-induced VSMC inflammation by reducing reactive oxygen species (ROS) production. Vascular smooth muscle cells (VSMC) from WKY rats were treated with 1 μM atorvastatin for 60 min or for 72 h prior to aldosterone (10

Indexed as

AldosteroneAngiotensin IIAnimalsAntioxidantsAtorvastatinCells, CulturedHydroxymethylglutaryl-CoA Reductase InhibitorsMaleMuscle, Smooth, VascularMyocytes, Smooth MuscleNADPH OxidasesOxidation-ReductionOxidative Stressrac1 GTP-Binding ProteinRAC2 GTP-Binding Proteinrac GTP-Binding ProteinsAldosteroneAngiotensin IIAntioxidantsAtorvastatinHydroxymethylglutaryl-CoA Reductase InhibitorsNADPH Oxidasesneutrophil cytosolic factor 1rac1 GTP-Binding ProteinRac1 protein, ratRAC2 GTP-Binding Proteinrac GTP-Binding ProteinsReactive Oxygen SpeciesInflammationMineralocorticoidsRedox signalingStatinsVascular

Identifiers

PMID30721707
PMCPMC6686670
OpenAlexW2914243390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.